Pharmacokinetics of afatinib, a selective irreversible ErbB family blocker, in patients with advanced solid tumours. [electronic resource]
Producer: 20140708Description: 1101-9 p. digitalISSN:- 1179-1926
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.